Loading company…
Lykos Therapeutics develops therapies for PTSD and other mental health conditions.
Lykos Therapeutics conducts mental health research and provides training for therapists in MDMA-assisted therapy. It also supports research for healthcare providers. Founded in 2014, the company is based in San Jose, US. It raised Series A funding led by Helena Capital in January 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in